Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$81.88

-0.17 (-0.21%)

17:19
06/18/17
06/18
17:19
06/18/17
17:19

Eli Lilly granted Orphan designation for pediatric colitis treatment

The FDA has granted Eli Lilly Orphan designation for its "humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin-23" product in the treatment of ulcerative colitis in pediatric patients. The designation was granted June 15. Reference Link

LLY Eli Lilly
$81.88

-0.17 (-0.21%)

06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Eli Lilly has positive read through from J&J data, says SunTrust
SunTrust analyst John Boris says that data for Johnson & Johnson's (JNJ) Invokana for diabetes represented a best-case scenario for Eli Lilly (LLY). J&J's drug "significantly reduced the combined risk of cardiovascular death, myocardial infarction and nonfatal stroke in diabetes patients at risk for or with a history of CV diseases," and its efficacy on CV death is positive for the SGLT-2 class, to which Eli Lilly's Jardiance also belongs, according to the analyst. But the data leaves Jardiance, which reduced CV death by a statistically significant 38% versus Invokana's non-significant 13%, as the best in the class, wrote the analyst, who reiterates a $101 price target and a Buy rating on Eli Lilly.
06/12/17
LEER
06/12/17
NO CHANGE
Target $90
LEER
Outperform
Eli Lilly price target lowered to $90 from $93 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Eli Lilly (LLY) to $90 to reflect reduced sales forecasts for baricitinib, an oral JAK1/2 inhibitor to treat rheumatoid arthritis which the company collaborates with Incyte (INCY). Following AbbVie's (ABBV) positive Phase 3 data last week for its JAK1 inhibitor upadacitinib, Fernandez dropped his U.S. peak sales estimate for baricitinib by more than 50% to $400M and pushed out his U.S. launch time to 2020 from 2018. The analyst keeps an Outperform rating on Lilly shares.
06/07/17
FBCO
06/07/17
NO CHANGE
Target $38
FBCO
Outperform
ASCO meeting highlights pressure on Pfizer cancer assets, says Credit Suisse
Credit Suisse analyst Vamil Divan said he came away from the ASCO meeting feeling like positive progress by competitors is increasing the pressure on Pfizer's (PFE) cancer assets, specifically pointing to positive data for Roche's (RHHBY) Alecensa, Johnson & Johnson's (JNJ) Zytiga and Eli Lilly's (LLY) abemaciclib. Additionally, competition in the immune-oncology and PARP spaces will make it more challenging for Pfizer to gain traction, added Divan. He keeps an Outperform rating on Pfizer, citing valuation and its dividend yield, but he has concerns about its upcoming patent expirations and growth products.
06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).

TODAY'S FREE FLY STORIES

TROV

Trovagene

$0.95

0.0471 (5.24%)

08:02
06/22/17
06/22
08:02
06/22/17
08:02
Hot Stocks
Trovagene to provide Trovera tests and services for global pharma company »

Trovagene has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

08:02
06/22/17
06/22
08:02
06/22/17
08:02
Technical Analysis
Technical View: Hain Celestial up after earnings, buybacks, new CFO »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

TSLA

Tesla

$376.40

4.16 (1.12%)

08:01
06/22/17
06/22
08:01
06/22/17
08:01
Periodicals
Tianjin not participating in Tesla's China project at this time, Reuters says »

Tianjin Motors says it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MNK

Mallinckrodt

$45.37

2.06 (4.76%)

08:00
06/22/17
06/22
08:00
06/22/17
08:00
Options
Mallinckrodt call buyer realizes 74% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
06/22/17
06/22
08:00
06/22/17
08:00
General news
Breaking General news story  »

New York Federal Reserve…

ORCL

Oracle

$46.33

0.49 (1.07%)

07:59
06/22/17
06/22
07:59
06/22/17
07:59
Upgrade
Oracle rating change  »

Oracle upgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BRK.A

Berkshire Hathaway

$254,400.00

-1460 (-0.57%)

, BRK.B

Berkshire Hathaway

$169.62

-0.93 (-0.55%)

07:57
06/22/17
06/22
07:57
06/22/17
07:57
Hot Stocks
Berkshire to invest up to C$400M in Home Capital, provide C$2B line of credit »

Canada's Home…

BRK.A

Berkshire Hathaway

$254,400.00

-1460 (-0.57%)

BRK.B

Berkshire Hathaway

$169.62

-0.93 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$153.73

-0.34 (-0.22%)

, AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

07:56
06/22/17
06/22
07:56
06/22/17
07:56
Periodicals
McDonald's teams up with UberEats in Britain, Engadget reports »

McDonald's (MCD) is…

MCD

McDonald's

$153.73

-0.34 (-0.22%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

KMDA

Kamada

$7.50

-0.05 (-0.66%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Technical Analysis
Technical View: Kamada dives after withdrawing MAA for AAT therapy with EMA »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

NEP

NextEra Energy Partners

$35.11

0.03 (0.09%)

, NEE

NextEra Energy

$141.06

-0.9 (-0.63%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Conference/Events
NextEra Energy and NextEra Energy Partners to hold an investor meeting »

Investor Meeting to be…

NEP

NextEra Energy Partners

$35.11

0.03 (0.09%)

NEE

NextEra Energy

$141.06

-0.9 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

LLY

Eli Lilly

$82.64

-0.11 (-0.13%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Conference/Events
FDA Pediatric Oncology Subcommittee of Oncologic Drugs Committee holds a meeting »

The Pediatric Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SPLS

Staples

$8.66

-0.09 (-1.03%)

07:52
06/22/17
06/22
07:52
06/22/17
07:52
Recommendations
Staples analyst commentary  »

Staples LBO could work in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$36.71

0.58 (1.61%)

, QCOM

Qualcomm

$56.33

-0.46 (-0.81%)

07:51
06/22/17
06/22
07:51
06/22/17
07:51
Periodicals
TSMC receives 7nm chip orders from Qualcomm, DigiTimes reports »

TSMC (TSM) has secured…

TSM

TSMC

$36.71

0.58 (1.61%)

QCOM

Qualcomm

$56.33

-0.46 (-0.81%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$17.50

1.45 (9.03%)

07:50
06/22/17
06/22
07:50
06/22/17
07:50
Hot Stocks
Otonomy announces successful end-of-Phase 2 review by FDA for Otiprio »

Otonomy announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$16.30

-0.2 (-1.21%)

07:50
06/22/17
06/22
07:50
06/22/17
07:50
Technical Analysis
Technical View: Steelcase drops sharply after earnings and outlook »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

TRGP

Targa Resources

$40.68

-0.73 (-1.76%)

07:49
06/22/17
06/22
07:49
06/22/17
07:49
Recommendations
Targa Resources analyst commentary  »

Targa Resources guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:47
06/22/17
06/22
07:47
06/22/17
07:47
General news
Futures slightly higher ahead of claims data »

Stock futures are trading…

DHI

D.R. Horton

$33.97

-0.2 (-0.59%)

, FOR

Forestar Group

$16.30

-0.1 (-0.61%)

07:45
06/22/17
06/22
07:45
06/22/17
07:45
Hot Stocks
D.R. Horton reiterates proposal to acquire 75% of Forestar Group »

D.R. Horton (DHI) said…

DHI

D.R. Horton

$33.97

-0.2 (-0.59%)

FOR

Forestar Group

$16.30

-0.1 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPC

Edgewell Personal Care

$75.05

-0.67 (-0.88%)

07:45
06/22/17
06/22
07:45
06/22/17
07:45
Upgrade
Edgewell Personal Care rating change  »

Edgewell Personal Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$62.50

0.05 (0.08%)

07:44
06/22/17
06/22
07:44
06/22/17
07:44
Recommendations
Lumentum analyst commentary  »

Lumentum price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

PRIM

Primoris

$23.84

-0.77 (-3.13%)

07:42
06/22/17
06/22
07:42
06/22/17
07:42
Hot Stocks
Primoris announces new pipeline construction awards valued at about $53M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRSC

Sears Canada

$0.47

-0.115 (-19.69%)

07:42
06/22/17
06/22
07:42
06/22/17
07:42
Hot Stocks
Breaking Hot Stocks news story on Sears Canada »

Sears Canada trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.33

0.48 (1.05%)

07:41
06/22/17
06/22
07:41
06/22/17
07:41
Technical Analysis
Technical View: Oracle sharply higher after earnings, analyst actions »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

FCX

Freeport McMoRan

$11.21

-0.03 (-0.27%)

07:40
06/22/17
06/22
07:40
06/22/17
07:40
Periodicals
Freeport Indonesia says Grasberg operations normal despite strike, Reuters says »

Operations at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$94.29

5.61 (6.33%)

07:38
06/22/17
06/22
07:38
06/22/17
07:38
Recommendations
Clovis analyst commentary  »

Clovis price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.